Sermorelin
Growth hormone-releasing hormone (GHRH) analog studied for stimulating the pituitary's natural GH production.
Research Areas
Scientific Background
Sermorelin is a synthetic analog of the first 29 amino acids of growth hormone-releasing hormone (GHRH 1-29), the shortest fully functional fragment. It stimulates the anterior pituitary to produce and release GH in a physiological, pulsatile manner, preserving natural feedback regulation.
Purity & Provenance
Why quality matters for research validity
Sermorelin is a 29-amino-acid GHRH analog. Verify HPLC ≥98% purity and correct sequence via mass spectrometry.
Areas of Investigation
Laboratory Information
Technical specifications for research settings
This compound is intended for qualified scientific research only. Not for human or veterinary use. Not for diagnostic or therapeutic applications. Researchers must comply with all applicable regulations in their jurisdiction.
Store lyophilized at -20°C. Protect from light.
Lyophilized powder
>98% by HPLC
Soluble in bacteriostatic water
For in vitro endocrine research applications.
Deepen Your Research
Published literature and clinical trial registries
Published Literature
Sermorelin has been extensively researched as a GHRH analog. Walker et al. and others examined its role in the diagnosis of GH deficiency and its physiological stimulation of pituitary GH output while maintaining normal feedback loops.
Regulatory Classification
Sermorelin is offered as a research compound. Available for qualified research purposes only.
Important Research Notice
This information is compiled from scientific literature for educational purposes only. This website does not sell, distribute, or recommend any compounds for human use. All compounds discussed are for qualified research purposes only.